New Deal
Paul Hudson
CEO at SANOFI SA
Manager
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (24)
Key Relationships
Announcement Date
Deal Value
XIIDRA
Novartis
£4,066m
52 dealmakers
Seprafilm Adhesion Barrier
Baxter International
£270m
5 dealmakers
SYNTHORX
Sanofi
£1,902m
50 dealmakers
REGENERON
Institutional Investors
£3,989m
23 dealmakers
Principia Biopharma
£2,750m
35 dealmakers
Kiadis Pharma
£276m
37 dealmakers
KYMAB
£811m
68 dealmakers
Sanofi Bangladesh
Beximco Pharmaceuticals
£35m
14 dealmakers
Sanofi (allston Plant)
National Resilience
value n/a
4 dealmakers
Sanofi / Capgemini / Generali / Orange Jv
Assicurazioni Generali
13 dealmakers
Sanofi (dental Brands)
SEPTODONT
11 dealmakers
Translate Bio
£2,302m
KADMON
£1,375m
33 dealmakers
Amunix Pharmaceuticals
£756m
36 dealmakers
LIBTAYO
£876m
16 dealmakers
Sanofi Pakistan
Igi Investments
£20m
9 dealmakers
Sanofi (two Product Portfolios)
NEURAXPHARM
Provention Bio
£2,408m
76 dealmakers
Tzield Royalty Interest
Sanofi (11 Central Nervous System Brands)
PHARMANOVIA
3 dealmakers
Sanofi (portfolio Of Consumer Health Brands)
Stada Arzneimittel
28 dealmakers
QUNOL
19 dealmakers
Meiragtx Holdings
£24m
6 dealmakers
Graviton Bioscience